Marchex to Present at the 2022 Needham Virtual Growth Conference
Get Alerts MCHX Hot Sheet
Join SI Premium – FREE
SEATTLE--(BUSINESS WIRE)-- Marchex (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, announced today that members of the Marchex management team will attend the following conference:
24nd Annual Needham Growth Conference
Date: Wednesday, January 12th
Presentation Time: 1x1s only
About Marchex
Marchex’s award-winning conversation intelligence platform, featuring AI-powered sales engagement and marketing solutions, helps businesses turn strategic insights into the actions that drive their most valued sales outcomes. Our multichannel voice and text capabilities enable sales and marketing teams to deliver the buying experiences that today’s customers expect. Marchex is the trusted conversation intelligence partner for market-leading companies in critical industries, including many of the world’s most innovative and successful brands.
Please visit www.marchex.com, www.marchex.com/blog or @marchex on Twitter (Twitter.com/Marchex), where Marchex discloses material information from time to time about the company and its business.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220110005232/en/
Marchex, Inc.
Investor Relations
Trevor Caldwell, 206-331-3600
[email protected]
Source: Marchex, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SmartCentres Releases 2025 Environmental, Social and Governance Report
- Vesper Energy Breaks Ground on Nazareth Solar, Adding 201 MW to Its Growing Operating Portfolio
- BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial on Multiple Sclerosis Treatment
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Needham & Company, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share